MSD
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
See below for the Latest MSD News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD navigates the pandemic tapestry in COVID-19 fight
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
Join the community
Most Read
1. Asia Pacific care providers favour agentic AI over generative systems 2. APAC digital health venture funding stalls at $244m despite $2.65b headline 3. Generative AI in healthcare to hit $30.4b by 2032 on imaging boom 4. Tech solutions key to APAC healthcare yet outcomes still shaped by inequality—Deloitte 5. IHH Healthcare outlines sustainability roadmap to 2030 in strategy shiftResource Center
Partner Events
Event News
Co-Written / Partner
King Saud University Medical City secures win at Healthcare Asia Awards 2026
Its strategic engineering and governance initiatives enhance hospital efficiency and patient care across the medical city.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes